Tranexamic Acid
NDC 67457-197, tranexamic acid, injection, solution, from Mylan Institutional LLC.
- Product NDC
- 67457-197
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091657
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-197 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRANEXAMIC ACID100 mg/mL
Pharmacologic classes
Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-197-10 | 67457019710 | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (67457-197-10) / 10 mL in 1 VIAL, SINGLE-DOSE (67457-197-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6f033f1e-8c78-4c87-b870-6493944315ffNADAC price for package 67457019710
GET /v1/drugs/nadac/67457019710
Use it
Look up 67457-197 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-197 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-197. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.